ArticleHepatology communications2026

Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD.

Yuta Myojin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.